26 results
Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind,
placebo-controlled pilot ... CriticalCare #Delirium #EBM ... #VisualAbstract
Sepsis Treatment Overview #Management #EM #IM #PCC #Sepsis #Overview #BMJ
Sepsis Treatment ... Overview #Management #EM ... #IM #PCC #Sepsis
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678035/

Mycophenolate versus Azathioprine as Maintenance Therapy
for Induction Treatment ... LupusNephritis #VisualAbstract ... #Nephrology #EBM
REVISE - Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical
Ill Patients: A Pilot ... #Withholding #VisualAbstract ... #EBM
SALT-ED Trial - Balanced Crystalloids versus Saline in Noncritically Ill Adults

N Engl J Med 2018; 378:819-828
hospital-free days between treatment ... crystalloids and treatment ... #AKI #MAKE30 #VisualAbstract ... #EBM
TOPCAT - Spironolactone for Heart Failure with Preserved Ejection Fraction

N Engl J Med 2014; 370:1383-1392 https://www.nejm.org/doi/10.1056/NEJMoa1313731

CONCLUSIONS:
ejection fraction, treatment ... dCHF #Cardiology #EBM ... #VisualAbstract
Balanced Crystalloids vs. NormalSaline - My infographic about SALT-ED and SMART trial comparing crystalloids and saline
hospital-free days between treatment ... #Saline #AKI #VisualAbstract ... #LR #EBM #Nephrology
The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an
tranexamic acid for the treatment ... interventions #EBM ... PostPartum #Hemorrhage #VisualAbstract
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
the Preventive Treatment ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
the Preventive Treatment ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab